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Abstract
Background: Patients with acquired brain damage (ABD) have suffered a brain lesion that interrupts vital
development in the physical, psychological and social spheres. Stroke and traumatic brain injury (TBI) are the two
main causes. The objectives of this study were to estimate the incidence and prevalence of ABD in the population
of the Basque Country and Navarre in 2008, to calculate the associated cost of the care required and finally to
assess the loss in health-related quality of life.
Methods: On the one hand, a cross-sectional survey was carried out, in order to estimate the incidence of ABD
and its consequences in terms of costs and loss in quality of life from the evolution of a sample of patients
diagnosed with stroke and TBI. On the other hand, a discrete event simulation model was built that enabled the
prevalence of ABD to be estimated. Finally, a calculation was made of the formal and informal costs of ABD in the
population of the Basque Country and Navarre (2,750,000 people).
Results: The cross-sectional study showed that the incidences of ABD caused by stroke and TBI were 61.8 and 12.5
cases per 100,000 per year respectively, while the overall prevalence was 657 cases per 100,000 people. The SF-36
physical and mental component scores were 28.9 and 44.5 respectively. The total economic burden was calculated
to be 382.14 million euro per year, distributed between 215.27 and 166.87 of formal and informal burden
respectively. The average cost per individual was 21,040 € per year.
Conclusions: The main conclusion of this study is that ABD has a high impact in both epidemiological and
economic terms as well as loss in quality of life. The overall prevalence obtained is equivalent to 0.7% of the total
population. The substantial economic burden is distributed nearly evenly between formal and informal costs.
Specifically, it was found that the physical dimensions of quality of life are the most severely affected. The
prevalence-based approach showed adequate to estimate the population impact of ABD and the resources
needed to compensate the disability.
Background
Medicine and society as a whole have been more inter-
ested in the causes of the diseases that result in mortality
than in their consequences in terms of long term disability
[1]. In the case of acute lesions and diseases that affect the
brain, there is plenty of work in the literature analysing
their causes, including stroke and traumatic brain injury
(TBI) [2-6]. However, few studies have focused on the
overall population outcome of the sequelae following
acquired brain damage (ABD). It is recognised that the
permanent sequelae caused by TBI and stroke are one of
the main causes of disability [7,8] and that the direct costs
of stroke range between 2 and 4% of the health expendi-
ture in industrialised countries [5,6]. However the long-
term impact on the family and quality of life of the patient
has not been sufficiently well documented. Indeed, the
informal costs due to disability represent a largely hidden
burden on society [6]. Patients with ABD have suffered a
brain lesion that interrupts their vital development in
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any medium, provided the original work is properly cited.physical, psychological and social spheres [9]. Apart from
stroke and TBI, there are other less common causes such
as brain tumours, types of meningoencephalitis and the
multiple causes of brain anoxia. The classification of the
clinical types of patients as a function of a set of functional
criteria focussed on care is difficult. The most easily recog-
nisable problems are those involving movement and com-
munication. On the other hand, cognitive and behavioural
changes are more difficult to identify and, ultimately, it is
these which pose the greatest challenges for social and
work reintegration [9]. The natural history of these
patients varies depending on the aetiology. What they all
have in common is a transition to certain level of disability
that typically requires specific social and health care and
represents a great loss in quality of life [9].
Society assigns a level of priority to each type of
health problem and allocates resources accordingly.
Experts use sources of epidemiological information
(incidence, prevalence, mortality, loss in quality of life)
as well as economic data to define the overall impact
[10]. However, experts have suggested that the low level
of attention paid to disability-generating health problem
is in part due to the fact that information regarding the
disease is scattered and not readily accessible [11]. The
lack of estimates of the long-term impact of the non-
deadly conditions, such as ABD, encourages the implicit
belief that there is no problem or that their social
impact is smaller than it really is [10].
This study was specifically focussed on the conse-
quences of the disability linked to ABD, given that this
is the reason why it is a serious health problem. In rela-
tion to this, the objectives of the study were to estimate
the incidence and prevalence of ABD in the population
of the Basque Country and Navarre in 2008, to calculate
the costs required for its care, and finally to quantify the
loss in health-related quality of life (HRQL).
Methods
Two methods were used. First, a cross-sectional survey
was used to estimate the incidence of ABD and its con-
sequences in terms of costs and loss in quality of life,
from the evolution of a sample composed of patients
diagnosed with stroke and TBI. Second, a discrete event
simulation model was built to reproduce the natural his-
tory of both diseases (stroke and TBI). The models
included the incidence of stroke and TBI as well as
associated mortality in the general population together
with the incidence of ABD obtained in the survey to cal-
culate the prevalence of ABD [12].
Survey for patients with stroke and TBI
The scope of this study was the geographical area of the
Basque Country and Navarre, two regions in the north
of Spain, with a total population of 2.75 million, the
socio-demographic characteristics being similar in the
two areas. Thus, the health system covers the full popu-
lation basically through public hospitals and health cen-
tres, the PIB per person is similar, the economy is
mainly dedicated to industry and they share an intense
trend to ageing. The incidence of ABD was established
according to the degree of permanence of the disability.
Hospital records are of limited use, since in Spain the
main source of information, the Hospital Minimum
Data Set, is focused on identifying the causes of hospital
admission and not the consequences. In order to iden-
tify the incidence, and the economic and Health-Related
Quality of Life (HRQL) impact, a survey was used with
patients who had been diagnosed with stroke or TBI in
five hospitals in the area. Given the similar social and
demographic characteristics and health care require-
ments, it was assumed that the evolution of patients
admitted for stroke and TBI in the participating hospi-
tals could be extrapolated to the whole region of study.
Using the codes of the International Classification of
Diseases (ICD-9-CM), we defined the cases of stroke as
the number of hospital admissions with a main diagno-
sis code in the range 430-436, except for 433.10 and
435, and TBI for codes 800*, 801*, 803*, 804*, between
the 850* and 854*, and 959.01. The number of patients
that met those criteria was 5,259 for stroke and 1,696
for TBI in the whole population. The survey was carried
out between a year and 18 months after hospital admis-
sion. A random sample of 510 patients with stroke and
213 with TBI was selected from the lists of patients with
these conditions in 2006. The variables collected by the
survey were grouped under the following sections: social
and demographic variables (age, sex, work situation,
occupation, level of education and family living arrange-
ments), scales to measure levels of disability (the Barthel
Index [13] and the Lawton and Brody Instrumental
Activities of Daily Living (IADL) Scale [14]), support
required for carrying out activities of daily living (in a
residential home, day centre, formal home care, informal
care) and questionnaires concerning quality of life (SF-
36 [15] and EQ-5D [16]). Using the administrative
records of hospital admissions, patients or relatives were
contacted by telephone to arrange an appointment. The
study was approved by the Research Committee. The
patients were informed previously about the characteris-
tics of the research and its voluntary nature, and all of
them had to give their informed consent to be included
in the study. The personnel involved in the fieldwork
were specifically trained in completion of the question-
naire. In the cases when the patients could not be con-
tacted or declined to participate, the admission medical
report was analysed to assess the presence of ABD.
Diagnosis of ABD was established on the basis of the
following criteria: Barthel index score lower than or
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points on the Lawton-Brody scale. In the case of the
patients who declined to participate or it was not pos-
sible to contact, medical reports were reviewed to
identify patients who given their functional state at
admission would be likely to still present damage after
18 months. Patients were classified according to their
level of autonomy on the basis of the following inter-
vals of the Barthel index: 0-20, the group of maximum
disability, 25-60, 65-95 and 100, the group of maxi-
mum independence.
Estimation of the economic impact of the patients with
ABD
A bottom-up approach was adopted for the estimation
of costs, that is, first the costs associated with a sample
population with ABD were assessed to obtain an annual
cost per patient [17]. Then, the population costs of ABD
were calculated, multiplying the costs per patient by the
prevalence data obtained through discrete event simula-
tion. Costs were valued for the year 2008.
The ABD cost was considered to be zero for patients
who were independent, with no sequelae from their
acute event. For patients who, after their acute event,
needed help to carry out activities of daily living, the
availability of formal and informal support was assessed.
By formal support we mean those services that involve
payment, while informal support includes the various
different types of non-paid support, to compensate for
the disability of patients, provided by relatives and
friends. The questionnaire included items which mea-
sured the situation of patients in terms of capacity to
perform activities of daily living and the services
received to compensate for their disability. The assign-
ment of a number of hours per patient to the home
support service (formal andi n f o r m a l )r e l i e do nt h e
answers to the questionnaire given by the caregivers.
Unit costs were obtained from the care providers in
the region and were as follows: day centre (€40.94/day),
nursing home, i.e., residential home with a high level of
care (€77.57/day), residential care home (€62.05/day),
other types of residential homes (€50.96/day), home
support services (€18.07/hour) and personal alarm sys-
tem (€86.28/year). The assessment of the unit costs of
informal care was based on the revealed preferences
method, considering the cost of substituting for the ser-
vice [18]. To achieve this, the hours of informal care
recorded on the questionnaire were assigned the market
value of a similar service. The labour cost was estimated
at €11.59 per hour on the basis of Section O of the
Spanish Quarterly Survey of Labour Costs which applies
to “other social activities and services provided to the
community; personal services” [19]. The replacement
cost method assumes homogeneity between the quality
of the professional service and that delivered by informal
care. A maximum of 16 hours per day was set for calcu-
lation of the number of hours per month devoted by the
close relatives to care of the patient. Finally, unit costs
were multiplied by resources used for each individual.
This final result provided an estimate of the annual cost
per patient with ABD according to type of cost (formal
or informal), level of disability and nature of the disor-
der leading to the condition.
Impact on health of ABD
The section of the questionnaire intended to assess the
impact on health was based, on the one hand, on scales
to measure disability (Barthel index and IADL Scale),
and on the other hand, on health-related quality of life
questionnaires (EQ-5D and SF-36). However, ABD does
not explain all the loss of function, given that disability
may be due to many other causes. In order to distin-
guish the fraction attributed to ABD, the population-
wide prevalence of disability was obtained from the Bas-
que Country health survey and the results of this survey
were adjusted to the age structure of patients with ABD.
The Barthel index was used to measure the degree to
which patients were able to perform basic activities of
daily living, in which it is understood that scores below
96 generally imply disability. Further, the ability of
patients to carry out instrumental activities of daily liv-
ing was estimated using the IADL scale.
The EQ-5D questionnaire is a standardised instrument
to measure population valuations of their health status
with respect to five dimensions (mobility, self-care,
usual activities, pain/discomfort, anxiety/depression) and
three levels of severity (no problems, some or moderate
problems and extreme problems. Its utility values were
calculated on the basis of the results obtained with the
Spanish population [16,20]. The SF-36 is a health ques-
tionnaire designed to assess patients’ the level of health,
and corresponding quality of life [15,21]. It consists of
36 questions regarding eight aspects of health: physical
functioning, role-physical, bodily pain, general health,
vitality, social functioning, role-emotional and mental
health. Theses dimensions may also be summarised in
terms of two components describing physical and men-
tal health status. The results were compared with those
of the general population from the Basque Country
Health Survey for 2002 [22]. Given the fact that SF-36
scores of the general population change with age, they
were adjusted to the age structure of the sample with
ABD. Thus, the differences observed were divided
according to their origin: ABD and an age effect.
The magnitude of the observed change between the
two groups has been assessed by the age-adjusted effect
size. It is calculated by dividing the difference of the
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population, by the standard deviation of the baseline
value. Cohen defined a effect size of less than 0.2 as
non-significant, of between 0.2 and 0.5 as small, between
0.5 and 0.8 as moderate and with values greater than 0.8
as large [23].
Estimation of prevalence
Despite its importance, the prevalence of diseases such
as stroke or TBI is only known through reports from
surveys on small samples [24]. In this study, discrete-
event simulation models (DESMs) were used to calcu-
late the prevalence of disability in patients who had pre-
viously suffered a stroke or a TBI [25]. The use of this
type of models is steadily increasing across a wide vari-
ety of fields where it is necessary to make economic
assessments thanks, in particular, to their ability to
accurately reflect disease progression over time and flex-
ibility to obtain the results in the required form. The
main advantage of DES methods is that they can accom-
modate many entities with different characteristics at
the same time. Entities are patients or individuals whose
pathway representation is the object of the model.
When entities come in the system, they have to be char-
acterized using attributes according to which their
future will be determined. This flexibility enables the
inclusion of all the different age cohorts contained in
the population of interest. As the model runs and the
time advances, each individual experiences changes
related to its attributes. These changes are recorded,
and, in the end, they determine the number of inciden-
tal events and the number of entities of specific interest
(disability prevalence) across time. The probability of
events and the duration of processes are derived from
random and independent sampling from theoretical
(Gompertz, Dirichlet, Beta) and empirical distributions
[25,26]. Table 1 summarizes all the parameters used in
both models. Using distributions allows running many
times the model (200 replications) to obtain confidence
intervals by probabilistic sensitivity analysis [25,26]. The
model managed the competitive risks by introducing a
function obtained by comparison of both times; this
means that the next event to occur was the first in time.
The model was built using Arena Software version 10
(Rockwell) [26].
We used different models for the representation of the
natural history of stroke and of TBI, but both held to a
similar structure (Figure 1). The model begins by creat-
ing new incident cases on the basis of the incidence of
stroke and TBI year on year taken from the records of
t h ea r e a ss t u d i e d .T h ec o m p l e t ed e s c r i p t i o no ft h e
stroke model and its validation has already been pub-
lished [25]. The incidence of TBI and stroke between
1997 and 2007 was obtained from the Hospital
Minimum Data Set for hospitalised patients. These
records indicate a hospitalisation rate ranging between
40 and 70 per 100,000 people per year for TBI which is
notably lower than those referred to in the literature
and it is explained by the decreasing car accidents rate.
The annual incidence of stroke varied between 159 and
194 cases per 100,000 people. For this calculation transi-
ent ischemic attacks were not taken into account nor
were recurrent cases of stroke, which account for 25%
of the total figure [7,8]. ABD prevalence is an instant
measure defined as the number of individuals in a popu-
lation which remain disabled after having suffered a
stroke or a TBI [27]. Therefore, prevalence changes con-
tinuously through time, but we assumed that it
remained constant within each year to simplify the pre-
sentation of results [25]. The validation of the model
was carried out by comparing the outputs with the para-
meters that were associated with the epidemiology of
stroke and TBI in the Basque Country and Navarre.
Results
From an initial sample of 723 people, a total of 539 indi-
viduals were interviewed, of which 361 were diagnosed
with stroke and 178 with TBI (Table 2). At the time of
the interview, 142 individuals had died. In addition, the
interview was not carried out in 31 cases because
patients or their relatives declined to participate, and in
11 cases due to changes in address or errors in adminis-
trative identification data. In 31 of these 42 cases, the
presence of ABD was established from the clinical his-
tories and the admission forms. A total of 282 cases
were identified as ABD and this, projected over the total
number of patients admitted for stroke and TBI in the
populations studied during 2006, gave a rate of ABD of
61.8 per 100,000 people per year due to stroke and 12.5
cases due to TBI.
Table 3 shows the characteristics of individuals with
ABD by age, sex, work status, Barthel index criteria (for
t h ea s s i g n m e n to fA B D )a n ds c o r eo b t a i n e di nt h eE Q -
5D questionnaire as a function of the Barthel index
score. The cases of TBI corresponded to individuals
who where younger than cases due to stroke. The scores
obtained using the EQ-5D questionnaire fall for smaller
values of the Barthel index, and indeed negative values
are reached in the group with the highest level of
disability.
The annual costs per patient with ABD with respect
to the level of disability and the underlying illness are
shown in table 4. The average social cost per patient
was €21,040/year. This cost of care increases in line
with the degree of disability which is characterized by
lower Barthel index scores.
Table 5 shows the means for all of the eight SF-36
health dimensions obtained by the patients with ABD.
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Traumatic brain injury model parameters
Parameter Source Distribution Parameters
TBI incidence Entity: TBI TBI rates (HSU) Empirical
Barthel index Assign Barthel
group
TBI rates by Barthel index from our
study
Dirichlet Gamma (1,6)
Gamma (1,15)
Gamma (1,36)
Gamma (1,8)
Sex Assign sex TBI incidence by sex and age (HSU) Empirical
Age Assign age TBI incidence by sex and age (HSU) Empirical
Time until death by other causes with Assign time Death rates by sex and age (INE) Gompertz Men a = RR*e
-9.36
b = 0.085
Women a = RR*e
-12
b = 0.112
Stroke model parameters
Parameter Source Distribution Parameters
Stroke incidence Entity: Stroke Stroke rates (HSU) Empirical
Barthel index for first ever stroke Assign Barthel
group
Barthel Index distribution from our
study
Dirichlet Gamma (1,32)
Gamma (1,44)
Gamma
(1,105)
Gamma (1,16)
Sex Assign sex Stroke incidence by sex and age
(HSU)
Empirical
Age Assign age Stroke incidence by sex and age
(HSU)
Empirical
Time until death by other causes with Assign time Death rates by sex and age (INE) Gompertz Men a = RR*e
-9.36
b = 0.085
Women a = RR*e
-12
b = 0.112
Time until recurrent stroke Assign time Calibration Gompertz Men a =e
-9.0
b = 0.085
Women a =e
-9.7
b = 0.090
Barthel index for recurrent stroke from
G0 to
G0 Barthel Index distribution from our
study
Dirichlet Gamma (1,2)
Death Gamma (1,9)
Barthel index for recurrent stroke from
G1 to
G0 Barthel Index distribution from our
study
Dirichlet Gamma (1,5)
G1 Gamma (1,7)
Death Gamma (1,18)
Barthel index for recurrent stroke from
G2 to
G0 Barthel Index distribution from our
study
Dirichlet Gamma (1,7)
G1 Gamma (1,9)
G2 Gamma (1,24)
Death Gamma (1,16)
Barthel index for recurrent stroke from
G3 to
G0 Barthel Index distribution from our
study
Dirichlet Gamma (1,13)
G1 Gamma (1,18)
G2 Gamma (1,48)
G3 Gamma (1,49)
Death Gamma (1,32)
HSU, Health Statistics Unit in the Spanish Government. ABD, acquired brain damage. INE, Statistics Spanish Institute. RR, relative risk. TBI, Traumatic brain injury.
HSU, Health Statistics Unit in the Basque and Navarre Governments. INE, Statistics Spanish Institute. RR, relative risk.
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negative perception of health appears in the dimensions
of physical functioning and role-physical (with average
scores of 32.4 and 38.8 respectively). The factor with the
best perception of health was the role-emotional (score
of 74.7), followed by bodily pain (67.2). A comparison of
the quality of life of patients with ABD with respect to
the general population in the various dimensions of the
questionnaire SF-36 is also shown in Table 5, including
the crude and the age-adjusted results. The summary
“physical” and “mental” scores show that the loss in
quality of life in patients with ABD is more marked in
the first component, 12.3 versus 6.0. With respect to the
physical component, 60.9% of the difference of the qual-
i t yo fl i f eo b s e r v e db e t w e e nt h eg r o u p sw a sd u et of a c -
tors linked to ABD. The remaining 39.1% (7.9 points
over the observed difference of 20.2) was explained by
age-structure differences. The last column of Table 5
indicates that for the physical function and role-physical
the effect size was high, while in the dimensions related
to mental aspects (role-emotional, mental health), the
effect size was only moderate and for pain was minimal.
The prevalence according the level of disability by the
index of Barthel and by age is shown in table 6. There
were an estimated 657 cases per 100,000 people of
whom 60% were due to stroke and 40% to TBI. To esti-
mate the economic burden, the cost per patient was
multiplied by the prevalence, in each case separating
according to Barthel level. In this way, the overall bur-
den is obtained and broken down according to the for-
mal and informal costs depending on the underlying
illness (Table 7). The total cost of the burden was esti-
mated at €382.14 million per year, with €215.27 million
corresponding to formal burden and €166.87 million to
informal burden.
Discussion
This work answers the lack of existing empirical data
on ABD in Spain. In particular, it should be empha-
sised that a substantial number of people experience a
loss in their level of independence and quality of life
(18,408) which represents 0.7% of the total population.
If we see the burden of ABD as an iceberg, the con-
ventional view, based on hospital admission records,
only allows us to see the tip that emerges on the sur-
face corresponding to the incidence of stroke and TBI.
Our study has quantified the prevalence rate, and it is
this that makes it possible to assess the overall extent
of the burden of ABD at population level, and its asso-
ciated costs. In relation to this, the importance given
to estimates of incidence and prevalence, and the rela-
tionship between them, is being reversed. The tradi-
tional epidemiological paradigm has focused on the
study of diseases that cause mortality and, since the
aim is to control the causes, the relevant measure of
disease in question is the incidence as a function of
the prevalence of risk factors [27]. However in the new
paradigm, the interesting measure is the prevalence of
Incidence Assign age and time values
Distribution 
of ABD
Recurrence 
of the event
Prevalence by 
Barthel Index 
score
Deaths
No ABD
Figure 1 Conceptual model of ABD starting from the illness
causing the condition. ABD: acquired brain damage.
Table 2 Distribution of patients by illness causing the condition and presence of acquired brain damage.
Stroke TBI Total
Number Percentage Number Percentage Number Percentage
ABD 214 42,0 68 31.9 282 39.0
Criteria ABD
Barthel < 100 173 80.8 55 80.9 228 80.9
Stopped working 1 0.5 2 2.9 3 1.1
Medical Reports 26 12.1 5 7.4 31 11.0
IADL (<4 M, <7 W) 14 6.5 6 8.8 20 7.1
No ABD 173 33.9 115 54 288 39.8
Deceased 116 22.7 26 12.2 142 19.6
Missing information 7 1.4 4 1.9 11 1.5
Total 510 100.0 213 100.0 723 100.0
TBI: traumatic brain damage; ABD: acquired brain injury; IADL: instrumental activities of daily living.
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such as stroke and TBI [24,28], because the calculation
of resources required to take care of disabled patients
is dependent on this.
The percentage of deaths is higher for stroke, due not
only to the greater severity of this condition, but also to
the age distribution for each of the diseases. Specifically,
studies carried out in the nineteen-nineties show higher
incidence rates of traumatic head injury in younger indi-
viduals [2]. However, the combination between a
decrease in the number of traffic accidents and the age-
ing of the population has meant that currently the high-
est rates of admissions for TBI are in individuals over
65 years old.
The literature reports data on costs of other diseases
in Spain. For comparison, the annual cost of AIDS per
patients is estimated to be €15,750, the costs associated
with Alzheimer €28,198 per year, and with degenerative
ataxia, €18,776 per year [29-31]. The mean social cost
per patient that we have obtained is €21,040, just a little
less than the mean cost per patient with Alzheimer’s
disease. However it should be taken into account that in
the aforementioned studies, health care as well as non-
health related costs were included, while in our work
only social costs were included. The reason for this
focus is that we specifically wanted to highlight the sub-
stantial costs due to long term sequelae and to loss in
independence with respect to the carrying out activities
Table 3 Characteristics of the sample with ABD by illness causing the condition.
Stroke (214 cases) TBI (68 cases) Total ABD (282 cases) No ABD (288 cases)
Number Percentage Number Percentage Number Percentage Number Percentage
Age Group
44 years or younger 3 1.40 7 10.29 10 3.55 64 22.30
From 45 to 54 years 9 4.21 7 10.29 16 5.67 27 9.41
From 55 to 64 years 20 9.35 6 8.82 26 9.22 44 15.33
From 65 to 74 years 44 20.56 11 16.18 55 19.50 75 26.13
From 75 to 84 years 94 43.93 22 32.35 116 41.13 63 21.95
Older than 84 years 44 20.56 15 22.06 59 20.92 14 4.88
Sex
Men 101 47.20 37 54.40 138 48.90 200 69.44
Women 113 52.80 31 45.60 144 51.10 88 30.56
Employment Status
Active 0 0.00 2 2.94 2 0.71 39 13.54
Retired 115 53.74 30 44.12 145 51.42 122 42.36
Disabled 13 6.07 11 16.18 24 8.51 8 2.78
Homemaker 34 15.89 8 11.76 42 14.89 14 4.86
Others 10 4.67 5 7.35 15 5.32 42 14.58
NA 42 19.63 12 17.65 54 19.15 63 21.88
Barthel Index
[0-20] 38 17.80 6 8.80 44 15.60 0 0.00
[25-60] 51 23.80 16 23.50 67 23.80 0 0.00
[65-95] 109 50.90 37 54.40 146 51.80 0 0.00
100 15 7.00 8 11.80 23 8.10 255 88.50
NA 1 0.50 1 1.50 2 0.70 33 11.50
IADL Index
≥4M ,≥7 W 38 17.76 17 25.00 55 19.50 246 85.42
<4 M, <7 W 150 70.09 46 67.65 196 69.50 0 0.00
NA 26 12.15 5 7.35 31 10.99 42 14.58
Mean SD Mean SD Mean SD Mean SD
EQ-5D
Barthel’s Index [0-20] -0.28 0.24 -0.21 0.21 -0.27 0.23
Barthel’s Index [25-60] 0.15 0.34 0.36 0.40 0.19 0.36
Barthel’s Index [61-95] 0.51 0.35 0.44 0.34 0.49 0.35
Barthel’s Index 100 0.83 0.20 0.77 0.30 0.81 0.23 0.91 0.17
TBI: traumatic brain injury; ABD: acquired brain damage; M: Men; W: Women.
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and TBI).
In the light of these data, it is clear that the care of
these patients is a great economic effort shared almost
equally between institutions and families. The estimated
care costs are equivalent to between 10.4 and 11.7% of
t h et o t a le x p e n d i t u r eo np ublic health in the Basque
Country and Navarra in 2008. Costs associated with the
pain and suffering caused by the condition were not
included, so the estimation given here is conservative.
The lack of standards for this type of assessment has led
to these costs also being omitted in other studies [31].
In addition, we have opted for using the replacement
method for the estimation of the costs associated with
informal care, that is, we assessed the services provided
by the informal carer taking into account that if they
did not provide their services, a professional carer
would have had to be hired. Basically, we asked how
much the replacing the informal carers would cost. This
approach does not take into account the heterogeneity
between the quality of professional service and that
delivered by informal care or other issues mentioned in
the literature such as that of multitasking (the perform-
ing of other tasks while taking care of the person with
limited independence) [32]. However, given the com-
plexity of assessing the cost of the time of carers, there
is no assessment method that is free of theoretical or
practical problems [33]. Indeed, the unit cost we have
used to assess the hours of informal care (€11.59/hour)
can be considered as conservative, when it is considered
that putting the replacement method into practice
would involve taking on the unit costs of a professional
home care provider (€18.07/hour).
As expected, the increase in the level of disability
measured using the Barthel index is correlated with an
increase in total costs per patients. However, informal
costs go down in the group with greater level of disabil-
ity. This is due to the fact that many more of these indi-
viduals are cared for in residential homes, so, the family
environment ceases to be pivotal in provision of care.
However, it remains the case most patients remain at
home, since in only 10% of cases the care is provided in
residential homes. This statistic emphasises the reality
Table 4 Annual cost per patient with ABD by cost type,
disability and illness causing the condition.
Total annual cost per patient
Barthel Group Total ABD Stroke TBI No ABD
[0,20] 44.550 44.270 45.904
[21,60] 40.813 42.822 34.015
[61,95] 16.484 17.488 13.725
[96,100] 3.391 4.268 1.748 413
Annual formal costs per patient
Barthel Group Total ABD ACVD TBI No ABD
[0,20] 35.377 34.274 40.704
[21,60] 22.992 24.183 18.959
[61,95] 7.650 8.626 4.965
[96,100] 1.474 1.394 1.626 398
Annual informal costs per patient
Barthel’s Group Total ABD Stroke TBI No ABD
[0,20] 9.173 9.995 5.200
[21,60] 17.822 18.639 15.056
[61,95] 8.834 8.861 8.761
[96,100] 1.917 2.874 122 15
TBI: traumatic brain injury; ABD: acquired brain damage.
Table 5 SF-36 Questionnaire Dimensions.
Patients with
ABD
General Population
(GP)
Observed
difference
ABD - GP
GP adjusted by age
(AGP)
Standardized
difference
ABD - AGP
Effect of
age
Effect
size
Physical
functioning
32.4 86.9 -54.6 66.4 -34.1 -20.5 1.6
Role physical 38.8 86.3 -47.5 76.0 -37.2 -10.3 1.2
Pain 67.2 77.3 -10.1 69.7 -2.4 -7.7 0.1
Perceived Health 44.1 65.6 -21.6 56.4 -12.4 -9.2 0.6
Vitality 44.3 65.5 -21.1 59.0 -14.6 -6.5 0.7
Social
functioning
56.2 88.8 -32.5 82.2 -26.0 -6.6 1.3
Role-emotional 74.7 91.3 -16.7 88.5 -13.9 -2.8 0.5
Mental Health 60.2 72.8 -12.5 69.5 -9.3 -3.2 0.5
Physical
component
29.1 49.4 -20.2 41.4 -12.3 -7.9 1.2
Mental
component
44.6 50.0 -5.4 50.6 -6.0 0.6 0.6
Comparison of patients with ABD and the general population adjusted by age.
Individuals from the interval [0-15] were not included. ABD: acquired brain damage. GP: General population. AGP: general population adjusted for age; Effect of
age: observed difference- standardized difference.
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Page 8 of 11that the family is still the main provider of care even for
patients with low levels of personal independence.
S t r o k ea n dT B Ir e p r e s e n tag r e a tr i s ko fl o s so fi n d e -
pendence since the prevalence of disability in patients
who have been admitted for TBI and stroke at some
point in their life is 44.0%. As for the degree of disabil-
ity, the differences in quality of life between individual
with ABD and the general populations are very large
despite the age adjustment. The only dimension that is
not significantly affected is that concerning pain. In the
dimensions physical functioning, role-physical, and
social function, individuals with ABD report that their
capacity to manage their own decisions in the spheres
of personal and social independence are greatly affected
compared to their contemporaries. The quality of life of
the individuals with ABD caused by stroke was found to
decrease more severely than cases due to TBI. This dif-
ference is particularly striking in the physical dimensions
such as physical functioning and role-physical and in
social functioning. The summary components of SF-36
fall as low as 28.9 in the physical and 44.5 in the mental
component, which in terms of effect size implies a very
severe deterioration in the physical quality of life and
moderate in the mental component.
At the start of this new century, Spain started with
low levels of expenditure on social cover associated with
long-term care in comparison to other European coun-
tries [34]. In Spain, the family has played a predominant
role as the main support network to cover for the needs
of disabled people. This phenomenon has been possible
thanks to lower proportions of middle aged women
being in work, and up to the present day has meant that
only subsidiary action has been required from the public
sector. That is, only now facing a shortfall or total lack
of the family support network, together with the limited
financial resources of dependent individuals, the Public
Administration has started to fund and provide within
the public system the necessary care. However, the
establishment of the System for Autonomy and Care for
Dependency (SAAD) has changed the legal framework
with the recognition of disability care as a right. This
law was drafted largely in response to an increase in the
demand for formal services due to the fact that the
social dynamics (smaller family size, increased number
of women working, etc.) make the system of family sup-
port that has dominated in Spain unsustainable in the
future. This means that a proportion of the estimated
extensive family resources (costs of informal care) will
have to be substituted in the long term by formal
resources funded publically or privately. Thus, a sub-
stantial proportion of the estimated costs that have been
“invisible” to date will show up in the future, and the
budgets and resources must be allocated to meet this
social demand.
Despite the fact that cost analysis studies have limita-
tions, the governments of many countries and regions
keep encouraging researchers to carry them out. The
reason for this is that decision-makers consider that
information concerning the financial impact caused by
Table 6 Prevalence of ABD in the Basque Country and
Navarre
STROKE G0 G1 G2 G3 Sum
From 0 to 15 years 0000 0
From 16 to 44 years 0 103 43 240 386
From 45 to 54 years 42 95 326 89 552
From 55 to 64 years 97 217 626 125 1.065
From 65 to 74 years 280 447 1.283 290 2.300
From 75 to 84 years 603 804 2.243 414 4.064
Older than 84 years 371 521 1.418 228 2.538
Sum 1.393 2.187 5.939 1.386 10.905
Upper CI 1.386 2.180 5.924 1.378 10.886
Lower CI 1.400 2.198 5.952 1.391 10.923
TBI G0 G1 G2 G3 Sum
From 0 to 15 years 0 137 0 94 231
From 16 to 44 years 0 326 308 720 1.354
From 45 to 54 years 0 179 277 292 748
From 55 to 64 years 0 157 350 285 792
From 65 to 74 years 74 185 519 231 1.009
From 75 to 84 years 112 259 895 143 1.409
Older than 84 years 68 375 1.031 486 1.960
Sum 254 1.618 3.380 2.251 7.503
Upper CI 259 1.630 3.395 2.260 7.526
Lower CI 250 1.610 3.367 2.238 7.482
Total G0 G1 G2 G3 Sum
From 0 to 15 years 0 137 0 94 231
From 16 to 44 years 0 429 351 960 1.740
From 45 to 54 years 42 274 603 381 1.300
From 55 to 64 years 97 374 976 410 1.857
From 65 to 74 years 354 632 1.802 521 3.309
From 75 to 84 years 715 1.063 3.138 557 5.473
Older than 84 years 439 896 2.449 714 4.498
Sum 1.647 3.805 9.319 3.637 18.408
Upper CI 1.658 3.828 9.347 3.652 18.449
Lower CI 1.635 3.790 9.291 3.615 18.368
TBI: traumatic brain injury; ABD: acquired brain damage; M: Men; W: Women.
G0: Barthel Group [0, 20]. G1: Barthel Group [21, 60]. G2: Barthel Group [61,
95]. G3: Barthel Group [96,100]. CI: Confidence Interval.
Table 7 Total annual costs (formal and informal) of ABD
by illness causing the condition (millions €).
Total costs Stroke TBI Total Costs
Euros % Euros % Euros %
Formal Costs 153.8 58.0 61.47 52.5 215.27 56.3
Informal Costs 111.3 42.0 55.57 47.5 166.87 43.7
Cost Total 265.09 100.0 117.04 100.0 382.14 100.0
ABD: acquired brain damage
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Page 9 of 11the diseases may be useful input for planning their pro-
grammes [35]. It does not substitute but is complemen-
tary to epidemiological information on population
health problems. The Spanish Ministry of Health and
Social Policy has included estimations of the associated
cost in the recent policy document entitled “Strategies
for Stroke in the National Health System”,i no r d e rt o
demonstrate the social significance of this health pro-
blem before proposing measures to prevent and care it
[36]. This growing level of interest suggests that the
ability of cost analysis studies to help us understand the
social impact of illness, may mean that they become a
useful tool for designing public policies [36,37].
In this way, this information may be taken into
account in policymaking, with the first step being make
available sufficient epidemiological data to identify the
level of importance of the problem under study. Sec-
ondly, an assessment needs to be made of the costs of
these illnesses and problems they present for the com-
munity (using the wide concept of social costs), as a
way of considering the loss of social wellbeing caused by
them. The third step would be to provide access to
information on the technical and human resources that
could be applied in policies and interventions addressing
these problems. After this, the logical step would be to
identify which programmes and cross-sector interven-
tions are efficient, that is those policies that achieve an
improvement in life expectancy and in quality of life of
the population with using minimum available resources.
T h ef o l l o w i n gs t e pw o u l db et op u ti n t op r a c t i c es a i d
interventions and their subsequent evaluation.
Conclusions
The main conclusion of this study is that ABD has a
high impact in both epidemiological and economic
terms as well as loss in quality of life. The overall preva-
lence obtained is equivalent to 0.7% of the total popula-
tion. The substantial economic burden is distributed
nearly evenly between formal and informal costs. Speci-
fically, it was found that the physical dimensions of
quality of life are the most severely affected. The preva-
lence-based approach proved to be adequate to estimate
the population impact of ABD and the resources needed
to compensate for the disability.
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